![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEfnL7RJzwIxVnrcKQb7E_VVSVHJn0JRV7Q7kkEBTdg6HiEipPgAjkwGwagR9IE5WxNlvwo38wgq6AwoDE0AudZBDafp3NHxijAjC_uDqy8Rz_gNsQGK3p-yz3FKobn2LUUyBbZlV-op2q/s1600/CCO_Amsterdam2013_CC_2013_Phase_III_and_SlideFeature.png)
Summary of Phase III Investigational Agents For HCV Discussed
*Free registration is required to download slides and view capsule summaries
*Free registration is required to download slides and view capsule summaries
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
No comments:
Post a Comment